Evogene (EVGN)
0.62
+0.01 (1.64%)
Upcoming Events
Latest Headlines
Evogene completes phase 1 trial of bacterial cancer treatment BMC128
June 2, 2026 7:00 AM - StreetInsider
Evogene Announces Successful Completion of Phase 1 Clinical Study of BMC128, a Rationally Designed Live Bacterial Product, in Combination with Nivolumab by its Subsidiary Biomica
June 2, 2026 7:00 AM - PR NewsWire
EverGen Infrastructure Reports Q1 2026 Results
May 28, 2026 5:57 PM - BizWire
Form 424B3 Evogene Ltd.
May 20, 2026 8:46 AM - SEC Filing
Evogene (EVGN) Tops Q1 EPS by 26c
May 20, 2026 7:03 AM - StreetInsider
Form 6-K Evogene Ltd. For: May 20
May 20, 2026 7:00 AM - SEC Filing
Evogene Reports First Quarter 2026 Financial Results
May 20, 2026 7:00 AM - PR NewsWire
Form 6-K Evogene Ltd. For: May 18
May 18, 2026 4:01 PM - SEC Filing
Form SCHEDULE 13G Evogene Ltd. Filed by: ARMISTICE CAPITAL, LLC
May 15, 2026 11:17 AM - SEC Filing
Evogene to Present at the 24th Schrödinger European User Group Meeting
May 12, 2026 8:00 AM - PR NewsWire
Evogene Schedules First Quarter 2026 Financial Results Release
May 7, 2026 8:00 AM - PR NewsWire
EverGen Infrastructure Reports Q4 & Year End 2025 Results
April 29, 2026 7:46 PM - BizWire
Form EFFECT Evogene Ltd.
April 16, 2026 6:05 AM - SEC Filing
Form 3 Evogene Ltd. For: Apr 01 Filed by: Ravzin Polina
April 9, 2026 4:01 PM - SEC Filing
Form EFFECT Evogene Ltd.
April 6, 2026 6:01 AM - SEC Filing
Form 6-K Evogene Ltd. For: Apr 02
April 2, 2026 4:05 PM - SEC Filing
Evogene receives Nasdaq notice for minimum bid price deficiency
April 2, 2026 4:01 PM - StreetInsider
Evogene Reports Receipt of Nasdaq Minimum Bid Price Notification
April 2, 2026 4:01 PM - PR NewsWire
Casterra completes commercial field trials for castor oil biofuel in Brazil
March 31, 2026 8:03 AM - StreetInsider
Casterra Announces Successful Commercial Field Trials in Brazil, Positioning Castor Oil as a Promising Candidate for Economically Viable Biofuel Feedstock
March 31, 2026 8:02 AM - PR NewsWire
Form F-3 Evogene Ltd.
March 26, 2026 4:31 PM - SEC Filing
Form S-8 Evogene Ltd.
March 26, 2026 4:29 PM - SEC Filing
Form POS AM Evogene Ltd.
March 26, 2026 4:27 PM - SEC Filing
Form 20-F Evogene Ltd. For: Dec 31
March 26, 2026 4:01 PM - SEC Filing
Form 3 Evogene Ltd. For: Mar 18 Filed by: RECANATI LEON
March 18, 2026 9:23 AM - SEC Filing
Form 3 Evogene Ltd. For: Mar 18 Filed by: Nimrodi Nir
March 18, 2026 8:28 AM - SEC Filing
Form 3 Evogene Ltd. For: Mar 18 Filed by: Percy Adrian John
March 18, 2026 8:24 AM - SEC Filing
Form 3 Evogene Ltd. For: Mar 18 Filed by: Tarcic Gabi
March 18, 2026 8:20 AM - SEC Filing
Form 3 Evogene Ltd. For: Mar 18 Filed by: Zhidkov Ilia
March 18, 2026 8:16 AM - SEC Filing
Form 3 Evogene Ltd. For: Mar 18 Filed by: Firon Sarit
March 18, 2026 8:14 AM - SEC Filing
Form 3 Evogene Ltd. For: Mar 18 Filed by: ELDAD YARON
March 18, 2026 8:09 AM - SEC Filing
Form 3 Evogene Ltd. For: Mar 18 Filed by: Haviv Ofer
March 18, 2026 8:07 AM - SEC Filing
Form 3 Evogene Ltd. For: Mar 18 Filed by: Falk Dan Michael
March 18, 2026 8:04 AM - SEC Filing
Evogene to Present Its Pharma Discovery Achievements at BIO-Europe Spring 2026
March 9, 2026 9:00 AM - PR NewsWire
Full Article List
